ICU Stock Analysis: Buy, Sell, or Hold?
ICU - SeaStar Medical Holding Corporation Common Stock
$4.79
-0.16 (-3.23%)
▼
5d:
+0.63%
30d:
+82.13%
90d:
+29.11%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026
28d
Get Alerted When ICU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
15 traders called ICU this week
89% bullish • 2 bearish
89% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ICU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ICU is currently trading at $4.79, which is considered extended relative to its 30-day fair value range of $2.79 to $4.56.
Technical Outlook: Technically, ICU is in a strong uptrend. The price is approaching resistance at $3.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ICU has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+108.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICU is in a strong uptrend. The price is approaching resistance at $3.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ICU has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+108.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.79 -
$4.56
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range (+5.0% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 108.8% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$2.79 -
$4.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.90
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$10.00
(+108.8%)
Revenue Growth (YoY)
68.9%
Share & Embed Analysis
Last updated: July 14, 2026 8:48 AM ET
Data refreshes hourly during market hours. Next update: 9:48 AM
Data refreshes hourly during market hours. Next update: 9:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
